View in EDS

Control Strategy Considerations for the Continuous Manufacturing of Low-dose Oral Solid Dosage Formulations.

Saved in:
Bibliographic Details
Title: Control Strategy Considerations for the Continuous Manufacturing of Low-dose Oral Solid Dosage Formulations.
Authors: Dumarey M; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Pepparedsleden 1, Mölndal, Gothenburg, 43183, Sweden. melanie.dumarey@astrazeneca.com., Ruiz Samblás C; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Pepparedsleden 1, Mölndal, Gothenburg, 43183, Sweden., Bautista M; Process Analytical Technologies at Synthetic Molecules Technical Development, F. Hoffmann-La Roche AG, Basel, Switzerland., Kim SS; Formulation Department, Continuous Manufacturing, Vertex Pharmaceuticals, Inc., Boston, USA., Doddridge GD; Product Development Science and Technology, AbbVie, North Chicago, Illinois, USA., Shier AP; Process Engineering & Analytics, GSK, Ware, UK.
Source: The AAPS journal [AAPS J] 2026 May 06; Vol. 28 (3). Date of Electronic Publication: 2026 May 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42091770
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Control Strategy Considerations for the Continuous Manufacturing of Low-dose Oral Solid Dosage Formulations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dumarey+M%22">Dumarey M</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Pepparedsleden 1, Mölndal, Gothenburg, 43183, Sweden. melanie.dumarey@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Ruiz+Samblás+C%22">Ruiz Samblás C</searchLink>; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Pepparedsleden 1, Mölndal, Gothenburg, 43183, Sweden.<br /><searchLink fieldCode="AU" term="%22Bautista+M%22">Bautista M</searchLink>; Process Analytical Technologies at Synthetic Molecules Technical Development, F. Hoffmann-La Roche AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kim+SS%22">Kim SS</searchLink>; Formulation Department, Continuous Manufacturing, Vertex Pharmaceuticals, Inc., Boston, USA.<br /><searchLink fieldCode="AU" term="%22Doddridge+GD%22">Doddridge GD</searchLink>; Product Development Science and Technology, AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Shier+AP%22">Shier AP</searchLink>; Process Engineering & Analytics, GSK, Ware, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101223209%22">The AAPS journal</searchLink> [AAPS J] 2026 May 06; Vol. 28 (3). <i>Date of Electronic Publication: </i>2026 May 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+of+Pharmaceutical+Scientists%22">American Association of Pharmaceutical Scientists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101223209 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-7416 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215507416%22">15507416 </searchLink><i>NLM ISO Abbreviation: </i>AAPS J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42091770
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1208/s12248-026-01250-x
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Control Strategy Considerations for the Continuous Manufacturing of Low-dose Oral Solid Dosage Formulations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dumarey M
      – PersonEntity:
          Name:
            NameFull: Ruiz Samblás C
      – PersonEntity:
          Name:
            NameFull: Bautista M
      – PersonEntity:
          Name:
            NameFull: Kim SS
      – PersonEntity:
          Name:
            NameFull: Doddridge GD
      – PersonEntity:
          Name:
            NameFull: Shier AP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 05
              Text: 2026 May 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1550-7416
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The AAPS journal
              Type: main
ResultId 1